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Abstract
Background:  Mammalian blood neutrophilic granulocytes are terminally differentiated cells,
possessing extensive heterochromatin and lobulated (or ring-shaped) nuclei. Despite the extensive
amount of heterochromatin, neutrophils are capable of increased gene expression, when activated
by bacterial infection. Understanding the mechanisms of transcriptional repression and activation
in neutrophils requires detailing the chromatin epigenetic markers, which are virtually undescribed
in this cell type. Much is known about the heterochromatin epigenetic markers in other cell-types,
permitting a basis for comparison with those of mature normal neutrophilic granulocytes.
Results: Immunostaining and immunoblotting procedures were employed to study the presence
of repressive histone modifications and HP1 proteins in normal human and mouse blood
neutrophils, and in vitro differentiated granulocytes of the mouse promyelocytic (MPRO) system.
A variety of repressive histone methylation markers were detectable in these granulocytes (di- and
trimethylated H3K9; mono-, di- and trimethyl H3K27; di- and trimethyl H4K20). However, a
paucity of HP1 proteins was noted. These granulocytes revealed negligible amounts of HP1 α and
β, but exhibited detectable levels of HP1 γ. Of particular interest, mouse blood and MPRO
undifferentiated cells and granulocytes revealed clear co-localization of trimethylated H3K9,
trimethylated H4K20 and HP1 γ with pericentric heterochromatin.
Conclusion: Mature blood neutrophils possess some epigenetic heterochromatin features that
resemble those of well-studied cells, such as lymphocytes. However, the apparent paucity of HP1
proteins in neutrophils suggests that heterochromatin organization and binding to the nuclear
envelope may differ in this cell-type. Future investigations should follow changes in epigenetic
markers and levels of HP1 proteins during granulopoiesis and bacterial activation of neutrophils.
Background
The epigenome of a specific tissue constitutes the total set
of chromatin modifications existing above the level of
DNA base sequence and mitotically inherited, conveying
stability to the differentiated state. In mammalian cells,
these epigenetic modifications consist primarily of DNA
methylation, histone post-translational modifications
and variants, and nucleosome remodeling mechanisms
[1-5]. With the increased availability of reagents and tech-
niques for defining epigenetic modifications, numerous
studies have been published describing the epigenomes of
various cell types. Examples of mammalian cells that have
been studied include mouse resting B lymphocytes [6],
and embryonic erythrocytes and fibroblasts [7].
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Granulopoiesis, the terminal differentiation of blood
granulocytes (primarily neutrophils or "polymorphs")
occurs within the bone marrow and is well-described [8].
In humans the process takes about two weeks, starting
from the myeloblast stage (ovoid nuclei with minimal
heterochromatin), exhibiting one week of differentiation
and mitosis, followed by one week of post-mitotic nuclear
and cytoplasmic differentiation [9]. During the post-
mitotic phase the non-dividing nucleus displays progres-
sive chromatin condensation and nuclear shape changes.
The normal human neutrophil nucleus has 3–4 lobes [8];
mouse neutrophils frequently possess ring-shaped nuclei
[10,11]. These modulations of neutrophil nuclear shape
and the considerable amount of heterochromatin located
adjacent to the nuclear envelope (NE) depend upon nor-
mal amounts of the integral NE protein lamin B receptor
(LBR; for a recent review on the structure of the NE, see
[12]). Without sufficient levels of LBR, the neutrophil
nucleus does not exhibit the normal lobulation or ring-
shape and the heterochromatin undergoes clumping
removed from the NE [13,14]. Other factors involved in
the differentiation of neutrophil nuclear shape include NE
lamin composition and microtubule integrity (for a
description of our current hypothesis, see [15]).
A recent study comparing the nuclear composition of
human neutrophils with a variety of myeloid leukemias
[16] concluded that normal mature neutrophils exhibit a
deficiency of mono-, di- and trimethylated histone H3
lysine 9 (H3K9), combined with an absence of hetero-
chromatin protein 1 (HP1) α, β and γ; whereas myeloid
leukemias possessed all of these markers. This observation
is somewhat puzzling, since LBR has been shown to inter-
act with HP1 proteins [17,18], and HP1 has been sug-
gested to mediate the association between
heterochromatin and LBR at the NE [19,20]. Furthermore,
since methylated H3K9 is a well-studied repressive epige-
Immunostaining of human blood neutrophils with various  methylated histone antibodies Figure 2
Immunostaining of human blood neutrophils with 
various methylated histone antibodies. Columns: DAPI 
(DNA stain); Cy3, antibody staining viewed by conventional 
epifluorescent microscopy. Abbreviations: monoMe, diMe 
and triMe, monomethylated, dimethylated and trimethylated 
lysine. Scale bar: 10 µm.
Wright-Giemsa stained smears of human and mouse blood Figure 1
Wright-Giemsa stained smears of human and mouse 
blood. Selected neutrophils are shown (top row, human; 
bottom row, mouse). Note that human neutrophils exhibit 
nuclear lobes frequently connected by thin strands. Mouse 
neutrophil nuclei are usually twisted ring-shapes, frequently 
exhibiting several small NE nodules. Scale bars: 10 µm.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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netic modification [21] and trimethylated H3K9 is con-
centrated at pericentric and centric constitutive
heterochromatin [22,23], the apparent absence of methyl-
ated H3K9 and HP1 would imply a unique combination
of factors in the epigenome of granulocytes.
In the present investigation, we demonstrate that human
and mouse granulocytes do possess methylated H3K9
(and other methylated histones), as well as low amounts
of HP1 γ. The same spectrum of epigenetic markers
(including detectable levels of HP1 α,  β and γ) was
observed in undifferentiated and granulocytic forms of
retinoic acid (RA) treated mouse promyelocytic cells
(MPRO) [24], which undergo complete and normal dif-
ferentiation in vitro [25]. Therefore, excepting the reduced
amounts of HP1 proteins, the global epigenome of gran-
ulocytes appears to be more consistent with other mam-
malian cell-types and various myeloid leukemias, than
has been previously suggested [16]. In the present study,
mouse blood and MPRO granulocytes revealed clear co-
localization of trimethylated H3K9, trimethylated H4K20
and HP1 γ with pericentric heterochromatin. This obser-
vation agrees with earlier observations of co-localizated
trimethylated H3K9 and trimethylated H4K20 in pericen-
tric heterochromatin of various cultured mouse cells
[23,26].
Results
Peripheral blood granulocytes possess various types of 
histone methylation
Wright-Giemsa stained smears of human or mouse
peripheral blood reveal the well-described nuclear mor-
phologies of neutrophilic granulocytes (Figure 1). Human
neutrophils normally exhibit 3–4 lobes; mouse neu-
trophils frequently show ring-shaped nuclei with numer-
ous NE nodules. In situ hybridization studies have clearly
demonstrated that nodules in female human granulocytes
(called "drumsticks") contain the inactive X chromosome
[27]. However, the situation appears to be somewhat dif-
ferent with mouse granulocytes, since nodules are more
frequent than the number of X chromosomes (unpub-
lished observations).
Slides were prepared from purified human granulocytes
for immunostaining with a variety of anti-methylated his-
tone antibodies. Some of the results from conventional
epifluorescent imaging are presented in Figure 2. The puri-
fied granulocytes were centrifuged onto polylysine-coated
slides, fixed with PFA, permeabilized and immunos-
tained. All of the anti-methylated histone antibodies gave
positive staining; but with varying intensities and varying
patterns of localization. Anti-di- and trimethyl H3K9 and
anti-mono-, di- and trimethyl H3K27 appeared to stain
granulocyte nuclei. The pattern of staining by anti-trime-
thyl H3K9 was especially intriguing, yielding several
intensely stained spots within each granulocyte nucleus.
Anti-di- and trimethyl H4K20 revealed a mixture of weak
nuclear and cytoplasmic staining.
Immunoblots were performed on acid extracts of purified
human blood granulocytes derived from one normal
male and one normal female. A gallery of representative
blots, including acid extracted HeLa cells, is presented in
Figure 3. Similar granulocyte protein loads were
employed in all blots; Hela protein loads were also
unchanged. All of the anti-methylated histone antibodies
gave positive staining of varying strengths and with vary-
ing intensities relative to the HeLa extract. An indication
of reaction strength was obtained by noting the exposure
times of the films. Consideration of both immunostain-
ing and immunoblotting data yielded a qualitative assess-
ment of the antibody reactions, and is summarized in
Table 1. With respect to anti-trimethyl H3K9, it is conceiv-
able that the contrasting results, comparing immunos-
Immunoblotting of human granulocyte extracts with various methylated histone antibodies Figure 3
Immunoblotting of human granulocyte extracts with various methylated histone antibodies. Samples: F, normal 
female; M, normal male; H, HeLa. Panels: a, dimethyl H3K9; b, trimethyl H3K9; c, monomethyl H3K27; d, dimethyl H3K27; e, 
trimethyl H3K27; f, dimethyl H4K20; g, trimethyl H4K20.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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taining with immunoblotting, reflects high local
concentrations within the pericentric heterochromatin,
but low total amounts of the protein modification in the
nucleus.
Heparinized whole mouse blood, diluted with DMEM
medium was centrifuged onto polylysine-coated slides,
fixed with PFA, permeabilized and immunostained. Gran-
ulocytes were stained with a variety of anti-methylated
histone antibodies and imaged by conventional epifluo-
rescent microscopy (Figure 4). Varying levels of reactivity
with all the antibodies was noted (summarized on Table
1). Of particular interest was the clear co-localization of
anti-trimethylated H3K9 and trimethylated H4K20 with
DAPI-bright pericentric heterochromatin, consistent with
earlier observations on mouse cells [22,23,26,28]. Confo-
cal images of mouse blood granulocytes doubly stained
for lamin B and anti-trimethylated H3K9 or trimethylated
H4K20 (Figure 5) demonstrate that NE nodules appear to
contain these pericentric heterochromatin markers. No
immunoblots were performed on mouse granulocytes,
since we were unable to obtain purified fractions suitable
for extraction.
MPRO granulocytes possess various types of histone 
methylation
The same panel of methylation-specific anti-histone anti-
bodies was tested on undifferentiated and RA-differenti-
ated MPRO cells by immunofluorescent and
immunoblotting techniques. Figure 6 presents the results
of immunostaining, with comparative staining by anti-
lamin B and DAPI. As with mouse blood granulocytes
(Figures 4 and 5), MPRO granulocytes (or undifferenti-
ated cells) were strongly stained by anti-trimethyl H3K9
and anti-trimethyl H4K20 in bright spots that co-localized
to DAPI-bright pericentric regions. More generalized
nuclear staining was obtained with anti-dimethyl H3K9,
anti-mono-, di- and trimethyl H3K27 and, less intensely,
with anti-dimethyl H4K20.
Immunoblotting experiments on acid extracts of MPRO
cells (undifferentiated "O", and granulocytes "RA") are
presented in Figure 7. As with the previous immunoblot-
ting data on extracts of human granulocytes (Figure 3),
the same protein loads were used in all gels and the reac-
tion intensities shown are from different exposure times.
The qualitative assessment of antibody reactivity, combin-
ing immunostaining and immunoblotting data is pre-
sented in Table 1. No systematic changes in reaction
intensities were observed comparing undifferentiated
with RA-treated granulocytic MPRO cell extracts. Also, as
described for human granulocyte extracts, anti-trimethyl
H3K9 displayed very weak immunoblotting reactivity.
Again we suggest that the low cellular level of trimethyl
H3K9 may yield strong immunostaining because of a high
local concentration in the pericentric heterochromatin.
Peripheral blood granulocytes are deficient in HP1 
proteins
Because of difficulties that we have experienced employ-
ing commercial anti-HP1 antibodies to immunostain
blood granulocytes, we decided to test the antibodies on
mouse NIH 3T3 cells, where numerous authors have dem-
onstrated localization of anti-HP1 on DAPI-bright inter-
phase pericentric heterochromatin [7,28-30]. Results with
our best antibodies for immunostaining (Chemicon anti-
HP1 α and γ) of NIH 3T3 cells are presented in Figure 8.
Our images closely resemble previously published data
Table 1: Summmary Of Granulocyte Immunochemistry*.
ANTIBODY HUMAN BLOOD 
GRANULOCYTES
MOUSE BLOOD 
GRANULOCYTES
MOUSE MPRO CELLS**
dimethyl H3K9 + N + N + N
trimethyl H3K9 + N g + N p + N p
monomethyl H3K27 + N + N + N
dimethyl H3K27 + N + N + N
trimethyl H3K27 + N + N + N
dimethyl H4K20 +/- N, C +/- N +/- N
trimethyl H4K20 + N, C + N p + N p
HP1 α 0‡ 0 +/- N, C
HP1 β 0‡ 0 +/- N, C
HP1 γ +/- N, C + N p + N p
*The results listed represent a qualitative assessment, combining data from immunostaining and immunoblotting. In the case of normal mouse 
blood, due to inadequate enrichment of granulocytes, no immunoblotting was performed.
** Identical immunostaining and immunoblotting results were obtained with undifferentiated and RA differentiated MPRO cells.
Abbreviations: N, nuclear staining; N g, nuclear coarse granules; N p, nuclear pericentric heterochromatin; N, C, nuclear and cytoplasmic staining.
Reaction intensity: +, moderate to strong; +/-, weak; 0, negligible.
‡ Moderate to strong staining in the cytoplasm only.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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[7,30], indicating a co-localization of HP1 α and γ on peri-
centric heterochromatin.
Examples of HP1 α,  β and γ immunostained human
"buffy coat" preparations are presented in Figure 9.
(Euromedex anti-HP1 antibodies were employed in this
experiment.) Granulocytes of the buffy coat showed no
nuclear staining by anti-HP1 α and β and only weak stain-
ing with anti-HP1 γ. Anti-HP1 α and β appeared to yield a
weak reaction with granulocyte cytoplasmic granules,
which was also seen using anti-HP1 γ. These granular
structures do not derive from the secondary antibody
(data not shown). Mononuclear cells (lymphocytes and
monocytes) of the buffy coat provided an internal positive
control for nuclear staining by anti-HP1 antibodies.
Immunoblotting experiments with whole cell extracts of
human granulocytes (Figure 10) generally agreed with the
immunostaining experiments; i.e., no clear evidence of
HP1 α or β, an indication of trace amounts of HP1 γ. Dif-
ferent sources of anti-HP1 β indicated the possibility of a
lower molecular weight cross-reacting antigen (the cyto-
plasmic granules?), which was not studied further.
Immunostaining experiments with anti-HP1 antibodies
were performed on buffy coat preparations from whole
mouse blood (Figure 11). Results clearly indicated negli-
gible staining by anti-HP1 α or β of mouse granulocytes,
with clear nuclear staining of blood monocytic nuclei.
However, anti-HP1 γ yielded granulocyte nuclear staining,
somewhat brighter in pericentric heterochromatin;
monocytic nuclei were also stained.
In summary (see Table 1), we conclude that peripheral
blood granulocytes possess negligible amounts of HP1 α
Immunostaining of mouse blood neutrophils with methylated  histone antibodies: confocal sections Figure 5
Immunostaining of mouse blood neutrophils with 
methylated histone antibodies: confocal sections. Top 
row: anti-trimethyl H3K9 (left); anti-lamin B (middle); 
merged images (right). Bottom two rows: anti-trimethyl 
H4K20 (left); anti-lamin B (middle); merged images (right). 
Slides were fixed in methanol. Scale bar: 10 µm
Immunostaining of mouse blood neutrophils with methylated  histone antibodies Figure 4
Immunostaining of mouse blood neutrophils with 
methylated histone antibodies. Columns: DAPI (DNA 
stain); Cy3, antibody staining viewed by conventional epifluo-
rescent microscopy. Abbreviations: monoMe, diMe and 
triMe, monomethylated, dimethylated and trimethylated 
lysine. Scale bar: 10 µmBMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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or β, and low levels of HP1 γ. On the other hand, blood
mononuclear cells do clearly stain for all HP1 isoforms.
MPRO granulocytes possess HP1 proteins
Immunostaining experiments were performed on undif-
ferentiated and granulocytic MPRO cells (Figure 12). The
most convincing nuclear staining was with anti-HP1 γ,
which yielded a combination of diffuse nuclear staining
and focal staining, which co-localizes with DAPI-bright
pericentric heterochromatin (panels A and B) and anti-tri-
methyl H4K20 (panel C). Both anti-HP1 α and β yielded
weak staining in the nucleus and the cytoplasm. Immuno-
Immunostaining of undifferentiated and granulocytic MPRO cells with various histone methylation antibodies Figure 6
Immunostaining of undifferentiated and granulocytic MPRO cells with various histone methylation antibodies. 
Panels: A, undifferentiated cells; B, granulocyte cells (4 days of RA). Columns: DAPI (DNA stain); Cy3, anti-methylated histone 
staining; Lamin B, FITC staining. Rows: monoMe, diMe and triMe, monomethylated, dimethylated and trimethylated lysines. 
Scale bar: 10 µm.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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blotting experiments were conducted upon extracts of
undifferentiated and RA-treated (4 days) granulocytic
MPRO cells (Figure 13). An extract of Hela cells was
included as a control. Convincing reactions with MPRO
extracts were observed with anti-HP1 β and γ. [Anti-HP1
α (Upstate) yielded no convincing reactivity with MPRO
or HeLa extracts.] MPRO HP1 β appears to possess a larger
molecular weight than measured in HeLa extracts (MPRO,
~33 kD; Hela, ~28 kD) and does not appear to decrease
during the differentiation process. The apparent molecu-
lar weight of HeLa and MPRO HP1 γ, as determined on
12% acrylamide SDS gels, was ~23–24 kD. Since the pro-
tein loads for the MPRO lanes was approximately the
same (Figure 13, panel a), the declining reactivity compar-
ing O and RA, suggests that the cellular level of HP1γ
decreases during the granulocytic differentiation process.
In summary, immunostaining and immunoblotting stud-
ies support the presence of HP1 γ in MPRO granulocyte
nuclei, with weaker evidence pertaining to HP1 α and β
(Table 1).
Discussion
Blood neutrophilic granulocytes are regarded as termi-
nally differentiated cells which are destined to undergo
apoptosis, but can be activated into a short-lived migra-
tory phagocytotic form by the presence of bacterial or
yeast infections [8]. Mature neutrophils possess consider-
able quantities of heterochromatin [9], suggesting tran-
scriptional repression. However, recent studies have
clearly demonstrated that neutrophil activation by bacte-
ria or bacterial lipopolysaccharide results in rapid and
extensive changes in gene expression [31-33]. Our labora-
tory has focused upon the cellular mechanisms of nuclear
shape change and heterochromatin distribution occurring
during granulopoiesis [11,13-15,34,35].
The cellular mechanisms producing progressive chroma-
tin condensation during granulopoiesis are not under-
stood. It seems reasonable to assume that described
features of constitutive and facultative heterochromatin
[21,23,26,36-41] apply to the situation of condensing
granulocyte chromatin. Some of these features include: 1)
hypoacetylation of histone lysines; 2) methylation of spe-
cific histone lysine residues (e.g., H3K9, H3K27 and
H4K20); 3) DNA methylation; 4) chromatin binding by
repressive proteins, such as HP1 α, β and γ. Our present
analysis of granulocyte nuclei only focuses upon two glo-
bal epigenetic features, repressive histone methylation
and HP1.
Repressive epigenetic features: histone methylation and 
HP1
Only one published study [16] has examined global epi-
genetic features of granulocyte heterochromatin. This
study concluded that normal human neutrophils are defi-
cient in methylated H3K9 and HP1 α, β and γ. Based upon
our present study, we agree that there is a paucity of HP1
α and β in normal human and mouse neutrophils, but we
can detect low amounts of nuclear HP1 γ. Futhermore,
undifferentiated and granulocytic forms of MPRO (mouse
promyelocytic) cells reveal detectable levels of HP1 α, β
and γ. It might be argued that MPRO granulocytes are not
normal differentiated cells, but resemble leukemic cells,
which do contain all isoforms of HP1 [16]. However,
MPRO cells are not derived from leukemic mice and the
in vitro granulocytic differentiation induced by RA is
Immunoblotting of MPRO granulocyte extracts with various histone methylation antibodies Figure 7
Immunoblotting of MPRO granulocyte extracts with various histone methylation antibodies. Samples: O, undif-
ferentiated; RA differentiated granulocytes; H, HeLa. Panels: a, dimethyl H3K9; b, trimethyl H3K9; c, monomethyl H3K27; d, 
dimethyl H3K27; e, trimethyl H3K27; f, dimethyl H4K20; g, trimethyl H4K20.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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believed to yield mature granulocytes [25], with a gene
expression pattern closely mimicking normal granulopoi-
esis [42,43].
A possible explanation for the apparent absence of HP1 α
and β in normal human neutrophils is degradation during
granulocyte preparation and extraction for immunoblot-
ting. Proteolysis is a definite problem when working with
granulocyte preparations, even in the presence of high
quantities of protease inhibitors (unpublished observa-
tions). Whatever the reasons, our evidence indicated that
low levels of HP1 γ are detectable in normal granulocytes.
The evident paucity of HP1 in the nuclei of mature neu-
trophils suggests that models postulating an essential role
for HP1 in the establishment of heterochromatin and its
adherence to the NE [20] may not be applicable to these
cell-types. On this issue, we are in complete agreement
with the earlier published discussion [16]. We cannot rule
out the possibility that HP1 proteins present early during
granulopoiesis fulfil a role in the establishment of hetero-
chromatin, which subsequently might be maintained by
low amounts of HP1 γ in the mature granulocytes.
The major disagreement between our study and the previ-
ous publication [16] concerns the existence of various iso-
forms of methylated H3K9. We describe
immunofluorescent and immunoblotting data support-
ing the presence of repressive methylated H3K9, H3K27
and H4K20 in normal human and mouse granulocytes
and MPRO undifferentiated and granulocytic forms. The
most dramatic images were obtained with trimethyl H3K9
and trimethyl H4K20 immunostained mouse blood and
MPRO granulocytes. In these situations, clear co-localiza-
tion with DAPI-bright pericentric heterochromatin was
demonstrated. Anti-trimethyl H3K9 yielded similar
intensely stained spots within human granulocyte nuclei.
But the pattern of DAPI staining in human granulocytes is
quite different than observed in mouse granulocyte nuclei
(compare Figures 2 and 4). In human granulocyte nuclei,
the DAPI-stained heterochromatin forms a thick layer
under the nuclear envelope and central masses within the
nuclear lobes. Several of the methylated histone antibod-
ies (anti-dimethyl H3K9 and anti-mono-, di- and trime-
thyl H3K27) appeared to generally stain human
granulocyte heterochromatin.
Formation of heterochromatin in the apparent absence of
HP1 has been reported previously [7]. Nucleated chicken
erythrocytes possess negligible amounts of HP1 α, β and
γ, reduced trimethyl H3K9 and very low amounts of tri-
methyl H3K27. However, reasonable levels of dimethyl
H3K9 were observed. In the same study, the authors dem-
onstrated significant levels of HP1 α, β and γ and trime-
thyl H3K9, but reduced trimethyl H3K27 in mouse
embryonic erythrocyte nuclei. More recently, in a study of
resting mouse lymphocytes [6], the authors describe low
levels of HP1 β, mono-, di- and trimethylated H3K9, tri-
methylated H3K27 and di- and trimethylated H4K20.
Activation of the lymphocytes resulted in increases in the
levels of all these epigenetic marks. In a variety of mouse
tissue culture cells, co-localization of trimethyl H3K9 and
trimethyl H4K20 on pericentric heterochromatin has
been clearly demonstrated [23,26]. A model for sequen-
tial trimethylation of H3K9 and H4K20 on pericentric
heterochromatin was presented [26], involving a stabiliz-
ing role for HP1 α and β binding to trimethyl H3K9 and
recruiting Suv4-20h to trimethylate H4K20. It remains to
be demonstrated whether HP1 γ could also serve as the
postulated intermediary, in the absence of HP1 α and β.
Histone variants and DNA methylation
An additional epigenetic feature of granulocyte nuclei,
described by us in an earlier publication [35], pertains to
histone H1 subtypes and phosphorylation. In a compari-
son of human neutrophils to leukemic HL-60 cells, we
concluded that granulocytic differentiation results in
dephosphorylation of subtypes H1.4, H1.5 and H1.2. Fur-
thermore, subtype H1.3 was observed in acid extracts of
normal human granulocytes, but not in those of undiffer-
entiated or RA differentiated HL-60 cells.
There is virtually no published information on the possi-
ble role of global DNA methylation in the establishment
of granulocyte heterochromatin. Given what is known
from other cell types concerning CpG methylation of peri-
centric heterochromatin [44,45], it seems reasonable to
assume a similar role for DNA methylation in granulo-
cytic cells. However, studies on the patterns and inhibi-
tion of DNA methylation during granulocytic
Immunostaining of mouse NIH 3T3 cells with HP1 antibodies Figure 8
Immunostaining of mouse NIH 3T3 cells with HP1 
antibodies. Columns: DAPI (DNA staining); Cy3, antibody 
staining of HP1 viewed by conventional epifluorescent micro-
scopy; Lamin B, FITC staining. Note the clear co-localization 
of HP1 staining with the DAPI-bright pericentric heterochro-
matin. Scale bar: 10 µmBMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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differentiation of HL-60 cells suggest that methylation is
not essential [46,47].
Neutrophil nuclear deformability
The present experiments, combined with earlier observa-
tions, provide a basis for understanding the mechanism of
granulocyte nuclear drumstick or nodule formation
observed in human or mouse blood smears. It appears
that nodules often contain pericentric heterochromatin
(mouse) or the inactive X chromosome (human [27]). We
have previously suggested that the NE of granulocytes is
highly deformable due to low levels of lamins A and B1
[11,15]. This view is based upon observations on HL-60
cells [15,34,48] and earlier studies of mouse granulocytes
[49,50]. Absence of lamin A in the NE has been shown to
increase NE deformability in mechanical strain tests [51],
consistent with conclusions from laminopathies [12].
There is now clear and convincing evidence that the com-
position and integrity of the lamin polymer strongly influ-
ences the NE strength [52]. Our view is that drumsticks
and nodules are artifacts of the flattening of granulocyte
nuclei, reflecting the more rigid heterochromatic foci
pushing against a deformable NE.
It seems reasonable to speculate that the altered composi-
tion of the granulocyte NE (i.e., paucity of lamins A and
B1, and elevation of LBR [35]) is an essential part of the
mechanism of nuclear lobulation [15] or formation of
ring-shaped nuclei [10,11]. Both the increased deforma-
bility of the NE and nuclear lobulation (or ring-shape)
may facilitate migration of activated neutrophils through
blood vessel endothelia and tight tissue spaces towards a
site of infection. The importance of granulocyte nuclear
lobulation for chemotactic migration through narrow
pores and tight spaces was demonstrated in a study of
individuals with Pelger Huet anomaly [53]. We have
shown NE deficiency of LBR in human Pelger Huet anom-
aly [13] and mouse ichthyosis [14], resulting in granulo-
cyte nuclear hypolobulation. One additional functional
consequence of increased granulocyte NE deformability
may be to facilitate the formation of neutrophil extracel-
lular traps (NETs) [54]. These structures appear to be an
extruded complex of chromatin and elastase that traps
and degrades invading bacteria.
Conclusion
Mature blood neutrophils possess considerable hetero-
chromatin containing a variety of repressive histone
methylation markers: di- and trimethylated H3K9; mono-
, di- and trimethyl H3K27; di- and trimethyl H4K20). In
addition, normal neutrophils exhibit negligible amounts
of HP1 α and β, but reveal detectable levels of HP1 γ.
Immunoblotting of human granulocyte extracts with various  HP1 antibodies Figure 10
Immunoblotting of human granulocyte extracts with 
various HP1 antibodies. Samples: F, normal female; M, 
normal male; H, HeLa. Panels: a, monoclonal anti-HP1 α 
(Upstate); b, monoclonal anti-HP1 β (Chemicon); c, rabbit 
anti-HP1 β (Upstate); d, monoclonal anti-HP1 γ (Chemicon). 
Note the trace reaction of anti-HP1 γ with the granulocyte 
extract (panel d).
Immunostaining of human blood buffy coat with various HP1  antibodies Figure 9
Immunostaining of human blood buffy coat with vari-
ous HP1 antibodies. Columns: Cy3, antibody staining 
viewed by conventional epifluorescent microscopy; DAPI 
(DNA staining). Note that the monocytic nuclei exhibit stain-
ing with all monoclonal anti-HP1 antibodies (Chemicon); 
whereas, the granulocytic nuclei only reveal staining with 
anti-HP1 γ. Anti-HP1 α, β and γ appear to stain cytoplasmic 
granules. Scale bar: 10 µm.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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Clear co-localization of trimethylated H3K9, trimethyl-
ated H4K20 and HP1 γ on pericentric heterochromatin
was demonstrated in normal mouse blood neutrophils
and granulocytic forms of mouse MPRO cells.
Methods
Cells enrichment and cultivation
Human peripheral blood preparations (from one normal
male and one normal female) were enriched for granulo-
cytes and monocytes by density gradient centrifugation
with HISTOPAQUE 1119 and 1077 (Sigma-Aldrich, Inc.),
following procedures described by the supplier. Granulo-
cytic and monocytic fractions were counted and examined
for purity using Wright-Giemsa stain (Sigma-Aldrich, Inc.,
St. Louis MO). For acid extraction of histones (see below),
the purified granulocytes were washed in RPMI medium
and used directly. For immunostaining (see below), the
granulocyte and monocyte fractions were pooled yielding
a "buffy coat", which was centrifuged onto polylysine-
coated slides.
Mouse blood was obtained in several ways. Separate
blood pools of adult NMRI male or female mice, collected
in EDTA-coated syringes, were centrifuged in HISTO-
PAQUE gradients. However, we routinely observed that
the granulocyte and monocyte bands were cross-contami-
nated. Therefore, the two fractions were combined to
yield a "buffy coat", which was suitable for immunostain-
ing, but not for acid extraction of histones. In other
immunostaining experiments with adult male CD1 mice,
small quantities (~80–100 µl) of blood were collected in
heparinized micro-hematocrit capillary tubes (Fisher Sci-
entific, Pittsburgh PA). The contents were expelled into
1.0 ml of DMEM and centrifuged onto polylysine-coated
slides.
MPRO (mouse promyelocytic) cells are a male cell line
derived from normal bone marrow and grown in medium
containing GM-CSF [24,25]. Following the addition of 10
µM RA, MPRO cells differentiate during four days into
apparently normal granulocytes with a mixture of ring-
shaped and lobulated nuclear forms [11]. Acid and SDS
extracts were prepared for immunoblots during the course
of RA-induced differentiation; immunostaining was per-
formed on cells centrifuged onto polylysine-coated slides.
Antibodies and immunostaining
Antibodies were obtained from a variety of private and
commercial sources. Our experience, especially with com-
mercial antibodies, is that they frequently do not react as
described and some exhibit different reactivities when the
same antibody is obtained in different lots. The most reli-
able anti-methylated histone antibodies were generously
provided by Thomas Jenuwein (Research Institute of
Molecular Pathology, University of Vienna, Vienna, Aus-
tria) and by David Allis (The Rockefeller University, New
York City), and are currently available from Upstate
(Charlottesville, VA). These are all rabbit antibodies, with
the following names and Upstate catalogue numbers:
anti-dimethyl H3K9, #07-441; anti-trimethyl H3K9, #07-
442; anti-monomethyl H3K27, #07-448; anti-dimethyl
H3K27, #07-452; anti-trimethyl H3K27, #07-449; anti-
dimethyl H4K20, #07-031; anti-trimethyl H4K20, #07-
463. Antibodies against the HP1 isoforms were purchased
from both Upstate and Chemicon International (Temec-
ula, CA) at various times and with varying success. We
never obtained acceptable immunostaining with Upstate
anti-HP1 α (#05-689) and (#07-346) or anti-HP1 β (#07-
333), although the anti-HP1 β was useful for immunob-
lots. Only the Chemicon anti-HP1 antibodies provided
useful immunostaining. Mouse anti-HP1 α (#MAB3584)
and anti-HP1 γ (#MAB3450) yielded clear immunostain-
Immunostaining of mouse blood buffy coat with various HP1  antibodies Figure 11
Immunostaining of mouse blood buffy coat with vari-
ous HP1 antibodies. Columns: DAPI (DNA staining); Cy3, 
antibody staining viewed by conventional epifluorescent 
microscopy. Note that the monocytic nuclei exhibit staining 
with all monoclonal anti-HP1 antibodies (Chemicon). Granu-
locytic nuclei only reveal staining with anti-HP1 γ, which 
appears more concentrated at pericentric heterochromatin. 
Scale bar: 10 µm.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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Immunostaining of MPRO cells with various HP1 antibodies Figure 12
Immunostaining of MPRO cells with various HP1 antibodies. Panels: A, undifferentiated; B, granulocyte forms of 
MPRO. Columns: FITC, antibody staining viewed by conventional epifluorescent microscopy; DAPI (DNA staining). Cells were 
stained with anti-HP1 α, β and γ. Note the co-localization of anti-HP1 γ with DAPI-bright pericentric heterochromatin. Panel 
C: confocal images demonstrating co-localization of anti-trimethylated H4K20 with anti-HP1 γ stained granulocyte pericentric 
heterochromatin. Scale bars: 10 µm.BMC Cell Biology 2005, 6:39 http://www.biomedcentral.com/1471-2121/6/39
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ing of NIH 3T3 cells (Figure 8), but only the anti-HP1 γ
was suitable for immunoblotting. Chemicon anti-HP1 β
(MAB 3448, lot # 24120319) did not work for immun-
ofluorescence or immunoblotting, although the same
antibody obtained earlier (Euromedex, Mundolsheim,
France; catalogue # 1MOD-1A9-AS), while visiting the
German Cancer Research Center, gave clean immunofluo-
rescent staining on NIH 3T3 cells. Goat anti-lamin B was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA;
catalogue # sc-6216). We have purchased this antibody
several times since 1997. Recently this antibody is
described as anti-lamin B1. Early lots of this antibody give
rim staining of human granulocyte NE; the more recent
lots have not given rim staining. We suspect that the ear-
lier lots reacted with both lamins B1 and B2, whereas the
more recent lots are more specific for lamin B1. The results
presented in this paper (Figures 5, 6 and 8) utilize the ear-
lier lots.
Immunostaining procedures have been described previ-
ously [11,15,35]. In brief, cells were centrifuged onto
fresh polylysine-coated slides and the cells fixed in 4% for-
maldehyde (PFA) in PBS for 15 min, or anhydrous meth-
anol (-20°, 10 min). PFA-fixed cells (most experiments)
were permeabilized with 0.1% Triton X-100, washed in
PBS and blocked with 5% normal donkey serum in PBS.
Methanol-fixed cells (Figure 5) went directly into PBS, fol-
lowed by blocking. Primary antibody dilutions followed
suggestions by the supplier. Secondary antibodies were
obtained from Jackson ImmunoResearch Laboratory
(West Grove PA).
Cell extracts and immunoblotting
The immunoblotting procedure has been described earlier
[35]. Most of the SDS-PAGE experiments were performed
with 15 or 12% precast BioRad gels. Secondary HRP-con-
jugated antibodies were obtained from Jackson Immu-
noResearch Laboratory. Several different ECL exposures
were collected on X-ray film and subsequently scanned
with a BioRad Chemi Doc.
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